Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02146274 · ClinicalTrials.gov registry record
Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research
A clinical trial of Stroke and Ischemic Stroke, sponsored by Duke University.
- Completed
- Registry status
- 1,877
- Enrollment target
- 1
- Study location
NCT02146274: Completed study of Stroke and Ischemic Stroke, sponsored by Duke University.
NCT02146274 is a study of Stroke and Ischemic Stroke that has completed, run by Duke University. The registered enrollment target is 1,877 participants, below the 12,012-participant average among 454 other Stroke trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02146274, a study of Stroke and Ischemic Stroke, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 1,877 participants
- Enrollment target
- 1
- Study location
Study Summary
PROSPER (Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research) is a three year research project to create a national, sustainable model to improve decision-making and patient-centered stroke outcomes through comparative effectiveness research.
Primary Outcome
Patient Health Questionnaire - 2 Item (PHQ-2) Higher score suggests more depression; range of 0-6. A score of two or higher suggests a diagnosis of major depression.
Conditions Studied
Study Locations (1)
North Carolina
- Duke Clinical Research Institute - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,877 participants |
| Start Date | 2013-11 |
| Est. Completion | 2017-12-31 |
What the finished NCT02146274 record still lists
NCT02146274 is an observational study that tracks outcomes without assigning an intervention. Its 1,877 participants enrollment target places it among the larger protocols in the corpus, below the 12,012-participant average among 454 other Stroke trials with a reported enrollment target (84% lower).
The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT02146274 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02146274 about?
NCT02146274 is a clinical study titled "Patient-centered Research Into Outcomes Stroke Patients Prefer and Effectiveness Research". PROSPER (Patient-centered Research into Outcomes Stroke patients Prefer and Effectiveness Research) is a three year research project to create a national, sustainable model to improve decision-making and patient-centered stroke outcomes through comparative effectiveness research.
What is the current status of trial NCT02146274?
This trial is currently completed. The enrollment target is 1,877 participants. The study started on 2013-11. Estimated completion is 2017-12-31.
What conditions does trial NCT02146274 study?
This clinical trial studies the following conditions: Stroke, Ischemic Stroke.
Who is sponsoring clinical trial NCT02146274?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02146274 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02146274's enrollment target sits among peer trials
1,877 27th of 454 higher than 428 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05675410 · 1,875 participants · Phase 3
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
- NCT06891898 · 1,875 participants
The iLet Experience Study
- NCT07356089 · 1,875 participants
Twiist Postmarket Surveillance Study for Type 1 Diabetes
- NCT06438640 · 1,881 participants · NA
Evaluating a Strategy to Improve Pre-Anesthesia Care Discussions (My Anesthesia Choice-Hip Fracture)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia